Candel Therapeutics, Inc. Common Stock (CADL)
Candel Therapeutics, Inc. Common Stock
XNAS:CADL
4.63
$4.60 - 4,000.00
$4.48 - 1,500.00
$4.42
$4.71
$4.67
$4.77
14.6
4.25
817514
686424.5
41058713.06
Chart
TendieTensor AI Analysis
Company
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Fundamentals
38
-8.530000
3.268110
-0.21
100
BBG00N0D4Z71
BBG00N0D4Z80
54.90M
54.90M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CADL. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.